HLB cuts HLB Biostep stake to 17.61% from 19.91% after off-market sale

• HLB cut its stake in HLB Biostep to 3,070,366 shares, or 17.61%, from 3,570,990 shares, or 19.91%.
• The disclosure dated the change to July 14, 2026, citing an off-market sale by related parties.
• Two affiliates sold 250,312 convertible bond rights each off-market to HLB Biostep at KRW 7,990.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HLB Biostep Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261013000400), on October 13, 2026, and is solely responsible for the information contained therein.